Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,515,692
-$35,035 QoQ
Shares Held
5,968
-5.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#2,599
of 4,676 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity Asset Management, Inc. holds $13,024,966 across 11 Drug Manufacturers - General names. JNJ ranks #3 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
8,729 | $3,160,945 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
31,404 | $1,809,498 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
5,968 | $1,515,692 | |
| 4 | GSK |
GSK plc
|
25,025 | $1,311,810 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,134 | $1,280,329 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,942 | $1,149,047 | |
| 7 | LLY |
ELI LILLY & Co
|
569 | $682,475 | |
| 8 | ABBV |
AbbVie Inc.
|
2,707 | $681,189 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,515,692 | 5,968 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,550,727 | 6,344 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,281,848 | 6,194 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,268,798 | 12,236 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $858,455 | 5,620 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,774,156 | 10,698 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $775,741 | 5,364 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,601,476 | 9,882 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $910,284 | 6,228 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $518,230 | 3,276 | Shares | Sole | 2024-05-28 | |
| 2023-12-31 | $512,226 | 3,268 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $498,867 | 3,203 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $641,555 | 3,876 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $1,186,990 | 7,658 | Shares | Sole | 2023-05-24 | |
| 2022-12-31 | $674,273 | 3,817 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $613,906 | 3,758 | Shares | Sole | 2022-11-16 | |
| 2022-03-31 | $742,770 | 4,191 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $584,717 | 3,418 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $513,893 | 3,182 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $693,061 | 4,207 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $486,640 | 2,961 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $406,984 | 2,586 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $220,640 | 1,482 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $275,635 | 2,102 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||